Strides Pharma Inc. recalls Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru -
Strides Pharma Inc. recalls 10mg Methoxsalen Capsules (50-count) with failed dissolution specs. Rx-only product manufactured in India, distributed in US. No remedy specified in recall notice.
Recall notice
Failed Dissolution Specifications
Contact the company & request your remedy
What happened, in plain English
Strides Pharma Inc. is recalling 10mg Methoxsalen Capsules (50-count bottles) that failed dissolution specifications. This means the capsules may not release medication properly when taken, potentially affecting treatment effectiveness. The recall is for prescription-only products distributed in the US. Read more at govinfonow.com/recall/32896-strides-pharma-recalls-methoxsalen-capsules-due-to-failed-dissolution-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/32896-strides-pharma-recalls-methoxsalen-capsules-due-to-failed-dissolution-specifications · Updated September 23, 2026 · FDA enforcement record: FDA #D-0260-2024
Cite this page
“Strides Pharma recalls Methoxsalen Capsules due to failed dissolution specifications.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32896-strides-pharma-recalls-methoxsalen-capsules-due-to-failed-dissolution-specifications. Based on FDA recall #D-0260-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0260-2024%22&limit=1).
Why it’s dangerous
The capsules failed dissolution specifications, meaning they may not release the medication properly in the body. This could lead to ineffective treatment if the medication doesn't dissolve correctly. The product is intended for prescription use only.
Who’s affected
Prescription-only Methoxsalen Capsules (10mg, 50-count) manufactured in India and distributed in the US. Patients using this medication under a doctor's supervision are most at risk.
How to tell if you have this one
Check for the 50-count bottle labeled 'Methoxsalen Capsules, USP 10mg' with NDC 64380-752-16. The product was manufactured by Strides Pharma Science Ltd. in Bengaluru, India, with lot number 7253092B and expiration date 09/30/2025.
- Brand
Strides Pharma- Category
Drug
What to do — step by step
Check Product Details
Look for the 50-count bottle labeled 'Methoxsalen Capsules, USP 10mg' with NDC 64380-752-16 and lot number 7253092B.
Questions people ask
Is this product safe to use?
The recall states the product failed dissolution specifications, but no specific safety risks are described. The product is prescription-only and intended for medical use.
What should I do if I have this product?
The recall notice does not specify a remedy, so no action is required beyond checking if you have the product.
When was this product manufactured?
The product was manufactured by Strides Pharma Science Ltd. in Bengaluru, India, with lot number 7253092B.
Contact Strides Pharma
We’ve drafted a message you can send Strides Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0260-2024 — Strides Pharma Strides Pharma Hello, I own a Strides Pharma that is covered by recall D-0260-2024 from Strides Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0260-2024 (December 29, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0260-2024 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.